Ji Wang
- Cancer Research top 1%
- MicroRNA in disease regulation 13
- Cancer-related molecular mechanisms research 10
- Molecular Biology top 5%
- Epigenetics and DNA Methylation 9
- RNA modifications and cancer 8
- Circular RNAs in diseases 8
- Immunology top 5%
- interferon and immune responses 8
- Oncology top 5%
-
- Neuroscience and Neuropharmacology Research 7
-
- Genetics and Neurodevelopmental Disorders 6
- Journals
- Oncotarget (7 papers)Biochemical and Biophysical Research Communications (4 papers)Medicine (4 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Ji Wang
135 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Cancer Research 1.2k
- Molecular Biology 2.2k
- Immunology 485
- Oncology 556
- Pulmonary and Respiratory Medicine 529
Countries citing papers authored by Ji Wang
This map shows the geographic impact of Ji Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji Wang more than expected).
Fields of papers citing papers by Ji Wang
This network shows the impact of papers produced by Ji Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji Wang. The network helps show where Ji Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ji Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 13 | |
| 6 | 2023 | 5 | |
| 7 | 2022 | 4 | |
| 8 | 2021 | 6 | |
| 9 | 2021 | 7 | |
| 10 | Cancer stage-dependent alterations in cell-free DNA in patients with colorectal cancer | 2021 | 5 |
| 11 | 2019 | 21 | |
| 12 | 2019 | 61 | |
| 13 | 2019 | 11 | |
| 14 | 2015 | 20 | |
| 15 | Advances in studies on pharmacological effects of luteolin | 2013 | 5 |
| 16 | 2012 | 112 | |
| 17 | Clinical application of preoperative embolization of tumor feeding artery combined with intraoperative balloon occlusion of the abdominal aorta in the resection of sacral tumors | 2012 | 2 |
| 18 | Radiosensitivity on Nasopharyngeal Carcinoma by CMNa | 2006 | 1 |
| 19 | Expression of Matrix metalloproteinases-10 in human ameloblastoma | 2004 | 2 |
| 20 | Volatile components of Korean soybean paste produced by Bacillus subtilis PM3 | 1995 | 13 |
About Ji Wang
Ji Wang is a scholar working on Cancer Research, Immunology and Molecular Biology, having authored 142 papers that have together received 3.9k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (13 papers), Cancer-related molecular mechanisms research (10 papers), Epigenetics and DNA Methylation (9 papers), interferon and immune responses (8 papers), RNA modifications and cancer (8 papers), Circular RNAs in diseases (8 papers), Neuroscience and Neuropharmacology Research (7 papers) and Genetics and Neurodevelopmental Disorders (6 papers). The work is most often cited by research in Cancer Research (1.2k citations), Molecular Biology (2.2k citations) and Immunology (485 citations). Ji Wang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Shaogang Qu, Dongmei Mai, Fushun Wang, Linbo Wang, Zhongxia Qi, Long-Cheng Li, Jingwei Yu, Jichun Zhou, Robert F. Place and Vera Huang. Their work appears in journals such as Oncotarget, Biochemical and Biophysical Research Communications, Medicine, Cell Death and Disease and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.